Exelixis, Inc. (EXEL)
USD 33.68
(-2.57%)
USD 33.68
(-2.57%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.83 Billion USD | 13.6% |
| 2022 | 1.61 Billion USD | 12.27% |
| 2021 | 1.43 Billion USD | 45.31% |
| 2020 | 987.53 Million USD | 2.04% |
| 2019 | 967.77 Million USD | 13.35% |
| 2018 | 853.82 Million USD | 88.7% |
| 2017 | 452.47 Million USD | 136.34% |
| 2016 | 191.45 Million USD | 415.05% |
| 2015 | 37.17 Million USD | 48.03% |
| 2014 | 25.11 Million USD | -19.87% |
| 2013 | 31.33 Million USD | -33.96% |
| 2012 | 47.45 Million USD | -83.62% |
| 2011 | 289.63 Million USD | 56.52% |
| 2010 | 185.04 Million USD | 21.93% |
| 2009 | 151.75 Million USD | 28.76% |
| 2008 | 117.85 Million USD | 3.87% |
| 2007 | 113.47 Million USD | 15.0% |
| 2006 | 98.67 Million USD | 29.9% |
| 2005 | 75.96 Million USD | 43.71% |
| 2004 | 52.85 Million USD | 2.56% |
| 2003 | 51.54 Million USD | 16.29% |
| 2002 | 44.32 Million USD | 8.09% |
| 2001 | 41 Million USD | 65.62% |
| 2000 | 24.75 Million USD | 135.8% |
| 1999 | 10.5 Million USD | 362.15% |
| 1998 | 2.27 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 478.05 Million USD | -15.32% |
| 2024 Q1 | 425.22 Million USD | -11.35% |
| 2024 Q2 | 637.17 Million USD | 49.84% |
| 2023 Q3 | 471.92 Million USD | 0.44% |
| 2023 Q4 | 479.65 Million USD | 1.64% |
| 2023 Q1 | 408.78 Million USD | -3.57% |
| 2023 Q2 | 469.84 Million USD | 14.94% |
| 2023 FY | 1.83 Billion USD | 13.6% |
| 2022 Q1 | 355.98 Million USD | -21.09% |
| 2022 Q4 | 423.91 Million USD | 2.96% |
| 2022 Q3 | 411.73 Million USD | -1.83% |
| 2022 FY | 1.61 Billion USD | 12.27% |
| 2022 Q2 | 419.42 Million USD | 17.82% |
| 2021 Q4 | 451.14 Million USD | 37.37% |
| 2021 FY | 1.43 Billion USD | 45.31% |
| 2021 Q1 | 270.23 Million USD | 0.07% |
| 2021 Q2 | 385.17 Million USD | 42.54% |
| 2021 Q3 | 328.42 Million USD | -14.73% |
| 2020 Q2 | 259.47 Million USD | 14.35% |
| 2020 FY | 987.53 Million USD | 2.04% |
| 2020 Q3 | 231.09 Million USD | -10.94% |
| 2020 Q4 | 270.05 Million USD | 16.86% |
| 2020 Q1 | 226.91 Million USD | -5.57% |
| 2019 FY | 967.77 Million USD | 13.35% |
| 2019 Q2 | 240.27 Million USD | 11.5% |
| 2019 Q1 | 215.48 Million USD | -5.74% |
| 2019 Q4 | 240.31 Million USD | -11.55% |
| 2019 Q3 | 271.7 Million USD | 13.08% |
| 2018 Q2 | 186.1 Million USD | -12.36% |
| 2018 FY | 853.82 Million USD | 88.7% |
| 2018 Q1 | 212.34 Million USD | 76.85% |
| 2018 Q3 | 225.39 Million USD | 21.11% |
| 2018 Q4 | 228.6 Million USD | 1.42% |
| 2017 Q2 | 99 Million USD | 22.4% |
| 2017 Q3 | 152.51 Million USD | 54.04% |
| 2017 FY | 452.47 Million USD | 136.34% |
| 2017 Q1 | 80.88 Million USD | 4.26% |
| 2017 Q4 | 120.07 Million USD | -21.27% |
| 2016 Q2 | 36.25 Million USD | 134.99% |
| 2016 FY | 191.45 Million USD | 415.05% |
| 2016 Q3 | 62.19 Million USD | 71.56% |
| 2016 Q4 | 77.58 Million USD | 24.74% |
| 2016 Q1 | 15.42 Million USD | 55.23% |
| 2015 FY | 37.17 Million USD | 48.03% |
| 2015 Q4 | 9.93 Million USD | 0.85% |
| 2015 Q3 | 9.85 Million USD | 23.3% |
| 2015 Q2 | 7.99 Million USD | -14.87% |
| 2015 Q1 | 9.38 Million USD | 27.68% |
| 2014 Q2 | 6.56 Million USD | 33.78% |
| 2014 Q3 | 6.29 Million USD | -4.13% |
| 2014 Q1 | 4.9 Million USD | 12.84% |
| 2014 Q4 | 7.35 Million USD | 16.88% |
| 2014 FY | 25.11 Million USD | -19.87% |
| 2013 Q1 | 9.66 Million USD | 23.74% |
| 2013 FY | 31.33 Million USD | -33.96% |
| 2013 Q2 | 11.85 Million USD | 22.62% |
| 2013 Q4 | 4.34 Million USD | -20.47% |
| 2013 Q3 | 5.46 Million USD | -53.9% |
| 2012 Q3 | 13.31 Million USD | 70.4% |
| 2012 Q4 | 7.81 Million USD | -41.31% |
| 2012 Q2 | 7.81 Million USD | -57.79% |
| 2012 Q1 | 18.51 Million USD | -80.16% |
| 2012 FY | 47.45 Million USD | -83.62% |
| 2011 FY | 289.63 Million USD | 56.52% |
| 2011 Q1 | 35.89 Million USD | -11.98% |
| 2011 Q2 | 32.16 Million USD | -10.39% |
| 2011 Q3 | 128.27 Million USD | 298.83% |
| 2011 Q4 | 93.3 Million USD | -27.26% |
| 2010 Q2 | 47.59 Million USD | 12.79% |
| 2010 Q4 | 40.77 Million USD | -25.15% |
| 2010 FY | 185.04 Million USD | 21.93% |
| 2010 Q1 | 42.19 Million USD | -4.26% |
| 2010 Q3 | 54.47 Million USD | 14.45% |
| 2009 Q1 | 25.3 Million USD | -14.44% |
| 2009 Q4 | 44.07 Million USD | -19.82% |
| 2009 Q3 | 54.97 Million USD | 100.63% |
| 2009 Q2 | 27.4 Million USD | 8.3% |
| 2009 FY | 151.75 Million USD | 28.76% |
| 2008 Q3 | 29.93 Million USD | -1.58% |
| 2008 Q2 | 30.41 Million USD | 8.83% |
| 2008 FY | 117.85 Million USD | 3.87% |
| 2008 Q1 | 27.94 Million USD | -4.46% |
| 2008 Q4 | 29.57 Million USD | -1.2% |
| 2007 Q1 | 28.13 Million USD | -5.49% |
| 2007 Q2 | 29.25 Million USD | 3.99% |
| 2007 Q3 | 26.82 Million USD | -8.32% |
| 2007 FY | 113.47 Million USD | 15.0% |
| 2007 Q4 | 29.25 Million USD | 9.04% |
| 2006 FY | 98.67 Million USD | 29.9% |
| 2006 Q1 | 18.11 Million USD | 26.03% |
| 2006 Q2 | 27.24 Million USD | 50.34% |
| 2006 Q3 | 23.54 Million USD | -13.58% |
| 2006 Q4 | 29.77 Million USD | 26.47% |
| 2005 Q3 | 14.4 Million USD | -58.03% |
| 2005 FY | 75.96 Million USD | 43.71% |
| 2005 Q2 | 34.31 Million USD | 166.51% |
| 2005 Q1 | 12.87 Million USD | -18.23% |
| 2005 Q4 | 14.37 Million USD | -0.16% |
| 2004 Q4 | 15.74 Million USD | 24.34% |
| 2004 FY | 52.85 Million USD | 2.56% |
| 2004 Q1 | 11.89 Million USD | -13.61% |
| 2004 Q3 | 12.66 Million USD | 0.82% |
| 2004 Q2 | 12.55 Million USD | 5.61% |
| 2003 Q1 | 12.33 Million USD | -0.99% |
| 2003 Q2 | 13 Million USD | 5.47% |
| 2003 Q3 | 12.43 Million USD | -4.35% |
| 2003 FY | 51.54 Million USD | 16.29% |
| 2003 Q4 | 13.76 Million USD | 10.67% |
| 2002 Q3 | 10.43 Million USD | 5.39% |
| 2002 Q1 | 11.56 Million USD | -9.64% |
| 2002 Q2 | 9.89 Million USD | -14.39% |
| 2002 FY | 44.32 Million USD | 8.09% |
| 2002 Q4 | 12.45 Million USD | 19.4% |
| 2001 Q2 | 8.55 Million USD | 10.56% |
| 2001 Q3 | 11.92 Million USD | 39.49% |
| 2001 Q4 | 12.79 Million USD | 7.25% |
| 2001 FY | 41 Million USD | 65.62% |
| 2001 Q1 | 7.73 Million USD | 9.33% |
| 2000 FY | 24.75 Million USD | 135.8% |
| 2000 Q2 | 5.61 Million USD | -5.63% |
| 2000 Q3 | 6.11 Million USD | 8.94% |
| 2000 Q1 | 5.95 Million USD | 0.0% |
| 2000 Q4 | 7.07 Million USD | 15.63% |
| 1999 FY | 10.5 Million USD | 362.15% |
| 1998 FY | 2.27 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -4713.17% |
| Alkermes plc | 1.66 Billion USD | -10.028% |
| Agenus Inc. | 156.31 Million USD | -1070.854% |
| Aptorum Group Limited | 431.37 Thousand USD | -424170.13% |
| Ardelyx, Inc. | 124.45 Million USD | -1370.566% |
| Dyadic International, Inc. | 2.89 Million USD | -63036.616% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -5684.11% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -702475.048% |
| Novavax, Inc. | 983.7 Million USD | -86.053% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -22542.682% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -9507.895% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -18319.968% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -228105.486% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -1016.566% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -22149.064% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -8717.73% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -0.105% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -660.258% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -431552.83% |
| Bicycle Therapeutics plc | 26.97 Million USD | -6684.579% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -132523.768% |
| ChromaDex Corporation | 83.57 Million USD | -2090.03% |
| Chimerix, Inc. | 324 Thousand USD | -564779.012% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -5208.49% |
| CRISPR Therapeutics AG | 371.2 Million USD | -393.044% |
| Precision BioSciences, Inc. | 48.72 Million USD | -3656.045% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -2780.72% |
| Fortress Biotech, Inc. | 84.51 Million USD | -2065.593% |
| Fortress Biotech, Inc. | 84.51 Million USD | -2065.593% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -8992.394% |
| ImmuCell Corporation | 17.47 Million USD | -10375.29% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -7726.419% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 50.477% |
| Innoviva, Inc. | 310.46 Million USD | -489.509% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -18650.21% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -1211958.278% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -1293.765% |
| ContextLogic Inc. | 287 Million USD | -537.703% |
| MiMedx Group, Inc. | 321.47 Million USD | -469.312% |
| MEI Pharma, Inc. | 65.29 Million USD | -2702.898% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -3130333.593% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -233047.516% |
| Opthea Limited | 261.85 Thousand USD | -698828.813% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -29300.932% |
| Pharming Group N.V. | 245.31 Million USD | -646.061% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -268258.944% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -4175.188% |
| PureTech Health plc | 3.33 Million USD | -54861.201% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -1465.86% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -19044.435% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -938.522% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -117674.003% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -71364.584% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -20745.194% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -36604060.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -1318.623% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -171912.03% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -1515.293% |
| Seer, Inc. | 15.18 Million USD | -11955.118% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -35618.345% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -7415.02% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -18301980.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -101578.222% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -840.386% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -359.616% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -66211.884% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -2812.535% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -15094.753% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -217948.296% |
| Century Therapeutics, Inc. | 2.23 Million USD | -81788.501% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -8594.988% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -1708.256% |
| Autolus Therapeutics plc | 1.69 Million USD | -107686.101% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -3877.157% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -2691382.353% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -974.848% |
| GRI Bio, Inc. | 21.76 Million USD | -8308.178% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -71955.83% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -85825.258% |
| INmune Bio, Inc. | 155 Thousand USD | -1180679.355% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -1340.61% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -81642.535% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -182920.8% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -21248.513% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -611.468% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -52191.657% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -115735.949% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -23460.865% |
| Histogen Inc. | 3.76 Million USD | -48459.512% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -313704.993% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -1678989.908% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -467153.348% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -5302.19% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -26606.669% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -1060.21% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1255186.694% |
| Apollomics, Inc. | 821 Thousand USD | -222824.239% |
| Amarin Corporation plc | 306.91 Million USD | -496.332% |
| Mesoblast Limited | 5.9 Million USD | -30909.963% |
| Turnstone Biologics Corp. | 19.3 Million USD | -9379.996% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -2228.746% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -942.776% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -2277.295% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -361.485% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -137406.236% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -1208.123% |
| Insmed Incorporated | 305.2 Million USD | -499.659% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -9694.541% |
| OmniAb, Inc. | 34.16 Million USD | -5257.124% |
| Alector, Inc. | 97.06 Million USD | -1785.607% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -1348.809% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -1776800.971% |
| Zai Lab Limited | 266.71 Million USD | -586.193% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -682.006% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1407752.308% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -10390.101% |
| Veracyte, Inc. | 361.05 Million USD | -406.911% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -39706.774% |
| FibroGen, Inc. | 147.75 Million USD | -1138.703% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -1238158.516% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 52.266% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -435663.81% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -380.64% |
| TG Therapeutics, Inc. | 233.66 Million USD | -683.272% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 41.132% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -117371.63% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -5258.536% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -2057.781% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -3087.183% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -321.465% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -3989.302% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -452.246% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -3316695.941% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -6938.179% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -20335544.444% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -55174.373% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 86.047% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -1498694.549% |
| Pluri Inc. | 326 Thousand USD | -561313.497% |
| Prothena Corporation plc | 91.37 Million USD | -1903.073% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -2936.127% |
| Celularity Inc. | 22.77 Million USD | -7937.451% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -33237.122% |
| MeiraGTx Holdings plc | 14.01 Million USD | -12957.059% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -633.762% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -2763.951% |
| Blueprint Medicines Corporation | 249.38 Million USD | -633.903% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -5805.992% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -24978.213% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -4945.37% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -36536.011% |
| Cytokinetics, Incorporated | 7.53 Million USD | -24205.551% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -87666.543% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -1366.572% |
| Evogene Ltd. | 5.64 Million USD | -32350.496% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -18214.9% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -19573.31% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -38029.333% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -4910.562% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -582768.79% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -91410.4% |
| MediciNova, Inc. | 1 Million USD | -182920.8% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -74693.952% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -10724822.356% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -576.352% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -95.155% |
| Mereo BioPharma Group plc | 10 Million USD | -18202.08% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -31907.835% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -8731.771% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -577.205% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -65148.057% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -279.416% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -1926434.737% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -38365.91% |
| Kezar Life Sciences, Inc. | 7 Million USD | -26045.829% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -8628.577% |
| aTyr Pharma, Inc. | 353 Thousand USD | -518372.521% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -11685.743% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -582768.79% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -15177012.53% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -120.706% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -808981.907% |
| UroGen Pharma Ltd. | 82.71 Million USD | -2112.721% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -1090.526% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -6619097.107% |
| Orgenesis Inc. | 530 Thousand USD | -345222.264% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -987.222% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -721667.696% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -850.066% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -808981.907% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -10724822.356% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -121670.326% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -35064.153% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -16600.502% |
| scPharmaceuticals Inc. | 13.59 Million USD | -13364.342% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -18160.082% |
| Daré Bioscience, Inc. | 2.8 Million USD | -65081.017% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -994578.261% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 25.564% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -15704.905% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -2950.347% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -6104.726% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 24.347% |
| DBV Technologies S.A. | 15.72 Million USD | -11536.623% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 73.274% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -22760.455% |
| Molecular Templates, Inc. | 57.3 Million USD | -3093.746% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -1160.144% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -18040.628% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -26490.266% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -3015.301% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -283575.772% |
| Adagene Inc. | 18.11 Million USD | -10005.231% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -169050.462% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -533.411% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -632.06% |
| SciSparc Ltd. | 2.87 Million USD | -63470.962% |
| Vericel Corporation | 197.51 Million USD | -826.613% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -30899.458% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -2970.51% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -7064.362% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -1791.981% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -1723.152% |
| ADMA Biologics, Inc. | 258.21 Million USD | -608.792% |
| Clene Inc. | 654 Thousand USD | -279748.318% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -7169.057% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -4005.907% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -3560.416% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -1710374.766% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -2023.704% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2503193.577% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -3031.612% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -15465.64% |
| Trevena, Inc. | 3.12 Million USD | -58466.656% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -151.943% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -29006.361% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -23137.786% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -294145.659% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -33531.165% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -2509.253% |
| Celularity Inc. | 22.77 Million USD | -7937.451% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -45506.977% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -1169967.575% |
| Cibus, Inc. | 1.81 Million USD | -100626.912% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -50739.111% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -25450.859% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -95025.156% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -132.364% |
| Eyenovia, Inc. | 3787.00 USD | -48328603.459% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -676.707% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -1559.014% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -374942.623% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2210.752% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -202121.979% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -772139.662% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -26938.085% |
| Royalty Pharma plc | 2.35 Billion USD | 22.269% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -249290.969% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -4865.969% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -1076492.941% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -151910.631% |
| Notable Labs, Ltd. | 310 Thousand USD | -590289.677% |
| Liquidia Corporation | 17.48 Million USD | -10365.508% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -169050.462% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -9988.793% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -98192.589% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -106767.531% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 21.366% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -2538259.546% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -38365.91% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -6100593.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -11452.156% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -2728.629% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -429526.291% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -358.29% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -5370.002% |
| Peak Bio, Inc. | 367.87 Thousand USD | -497405.416% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -6564.754% |
| Benitec Biopharma Inc. | 216 Thousand USD | -847218.519% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -206469.752% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -49.244% |
| Immunome, Inc. | 14.01 Million USD | -12956.128% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -110353.108% |
| CervoMed Inc. | 7.14 Million USD | -25515.686% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -37152.351% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -64663.199% |
| Moolec Science SA | 905.04 Thousand USD | -202121.979% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -219874.279% |
| AnaptysBio, Inc. | 17.15 Million USD | -10567.413% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -74297.217% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -82977.985% |
| Lumos Pharma, Inc. | 2.05 Million USD | -89134.91% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -4394.045% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -87666.543% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -897060.784% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -1525073.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -731983.2% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -384.555% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -882.008% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -4475.52% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -153828.343% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -11745.24% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -320989.123% |
| HCW Biologics Inc. | 2.84 Million USD | -64303.261% |
| XOMA Corporation | 4.75 Million USD | -38365.91% |
| Nektar Therapeutics | 90.12 Million USD | -1930.812% |
| Arvinas, Inc. | 78.5 Million USD | -2231.475% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -4064.58% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -59053.458% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -279748.318% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -104423.587% |
| Synlogic, Inc. | 3.37 Million USD | -54192.732% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -497405.416% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -9077.195% |
| Krystal Biotech, Inc. | 50.69 Million USD | -3509.949% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -1153.284% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -33500.294% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -406959.342% |
| MannKind Corporation | 198.96 Million USD | -819.878% |
| Ikena Oncology, Inc. | 9.16 Million USD | -19880.437% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -1513.229% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -541.856% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -45755100.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -3549.104% |
| REGENXBIO Inc. | 90.24 Million USD | -1928.111% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -81952.974% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -24702.927% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -242311.656% |
| Longeveron Inc. | 709 Thousand USD | -258039.351% |
| Repare Therapeutics Inc. | 51.13 Million USD | -3479.309% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -47.201% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -15704.905% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -871427.619% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 81.455% |
| Denali Therapeutics Inc. | 330.53 Million USD | -453.718% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -11130.366% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -67610.248% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -2263.755% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -1200587.529% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -12167.632% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -271041.926% |
| OmniAb, Inc. | 34.16 Million USD | -5257.124% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -8511.933% |
| Lipocine Inc. | -2.85 Million USD | 64299.398% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -81642.535% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -2118.138% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -2016.949% |
| Ocugen, Inc. | 6.03 Million USD | -30221.537% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -158222.491% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -4972.076% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -30392.256% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -288985.803% |
| Dominari Holdings Inc. | 2.03 Million USD | -89660.078% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -57.905% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -6723.279% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -214.457% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -14431.227% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -383591.405% |
| Iterum Therapeutics plc | - USD | -Infinity% |